206 related articles for article (PubMed ID: 19572156)
21. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
22. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
[TBL] [Abstract][Full Text] [Related]
23. Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO
Hon J; Hwang MS; Charnetzki MA; Rashed IJ; Brady PB; Quillin S; Makinen MW
J Biol Inorg Chem; 2017 Dec; 22(8):1267-1279. PubMed ID: 29071441
[TBL] [Abstract][Full Text] [Related]
24. Vanadyl complexes discriminate between neuroblastoma cells and primary neurons by inducing cell-specific apoptotic pathways.
Zhang Y; Wang L; Zeng K; Wang K; Yang X
J Inorg Biochem; 2018 Nov; 188():76-87. PubMed ID: 30121400
[TBL] [Abstract][Full Text] [Related]
25. Interaction of VO2+ ion and some insulin-enhancing compounds with immunoglobulin G.
Sanna D; Micera G; Garribba E
Inorg Chem; 2011 Apr; 50(8):3717-28. PubMed ID: 21434616
[TBL] [Abstract][Full Text] [Related]
26. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
[TBL] [Abstract][Full Text] [Related]
27. Stepwise Cluster Assembly Using VO(2)(acac) as a Precursor: cis-[VO(OCH(CH(3))(2))(acac)(2)], [V(2)O(2)(&mgr;-OCH(3))(2)(acac)(2)(OCH(3))(2)], [V(3)O(3){&mgr;,&mgr;-(OCH(2))(3)CCH(3)}(2)(acac)(2)(OC(2)H(5))], and [V(4)O(4)(&mgr;-O)(2)(&mgr;-OCH(3))(2)(&mgr;(3)-OCH(3))(2)(acac)(2)(OCH(3))(2)].2CH(3)CN(1).
Jiang F; Anderson OP; Miller SM; Chen J; Mahroof-Tahir M; Crans DC
Inorg Chem; 1998 Oct; 37(21):5439-5451. PubMed ID: 11670686
[TBL] [Abstract][Full Text] [Related]
28. Interaction of [V
Correia I; Chorna I; Cavaco I; Roy S; Kuznetsov ML; Ribeiro N; Justino G; Marques F; Santos-Silva T; Santos MFA; Santos HM; Capelo JL; Doutch J; Pessoa JC
Chem Asian J; 2017 Aug; 12(16):2062-2084. PubMed ID: 28651041
[TBL] [Abstract][Full Text] [Related]
29. A new gadolinium-based MRI zinc sensor.
Esqueda AC; López JA; Andreu-de-Riquer G; Alvarado-Monzón JC; Ratnakar J; Lubag AJ; Sherry AD; De León-Rodríguez LM
J Am Chem Soc; 2009 Aug; 131(32):11387-91. PubMed ID: 19630391
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
Martin VV; Ralston WH; Hynes MR; Keana JF
Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
[TBL] [Abstract][Full Text] [Related]
31. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
32. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
33. Effect of nonenzymatic glycosylation on the magnetic resonance imaging (MRI) contrast agent binding to human serum albumin.
Henoumont C; Laurent S; Muller RN; Vander Elst L
J Med Chem; 2012 Apr; 55(8):4015-9. PubMed ID: 22420713
[TBL] [Abstract][Full Text] [Related]
34. A hexanuclear gadolinium-organic octahedron as a sensitive MRI contrast agent for selectively imaging glucosamine in aqueous media.
He C; Wu X; Kong J; Liu T; Zhang X; Duan C
Chem Commun (Camb); 2012 Sep; 48(74):9290-2. PubMed ID: 22875137
[TBL] [Abstract][Full Text] [Related]
35. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
36. Speciation of potential anti-diabetic vanadium complexes in real serum samples.
Sanna D; Ugone V; Serra M; Garribba E
J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214
[TBL] [Abstract][Full Text] [Related]
37. MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
[TBL] [Abstract][Full Text] [Related]
38. New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum.
Sanna D; Micera G; Garribba E
Inorg Chem; 2010 Jan; 49(1):174-87. PubMed ID: 19947643
[TBL] [Abstract][Full Text] [Related]
39. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
[TBL] [Abstract][Full Text] [Related]
40. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.
Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E
J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
